IGF1R and Miyoshi myopathy: However, because these effects did not correlate with IGF1R expression or the CD45 phenotype of MM cells [31,33,34], it remains unclear what characterizes cells sensitive to IGF1R inhibition, highlighting the lack of biological or biomarker-based information [31].